HUM vs MXCT
Humana Inc (HUM) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the HUM and MXCT stock pages for the full models.
Not investment advice.